2 studies found for:    10601505 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
Condition: HIV Infections
Intervention: Drug: Kaletra
2 Completed CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Lopinavir/Ritonavir plus Lamivudine/Zidovudine;   Drug: Efavirenz plus Lamivudine/Zidovudine

Indicates status has not been verified in more than two years